Total Payments
$244,783
2024 Payments
$58,149
Companies
6
Transactions
484
Medicare Patients
311
Medicare Billing
$65,900
Payment Breakdown by Category
Other$144,279 (58.9%)
Travel$88,314 (36.1%)
Food & Beverage$11,230 (4.6%)
Consulting$960.00 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $128,054 | 73 | 52.3% |
| Travel and Lodging | $88,314 | 242 | 36.1% |
| Compensation for serving as faculty or as a speaker for a medical education program | $16,225 | 9 | 6.6% |
| Food and Beverage | $11,230 | 159 | 4.6% |
| Consulting Fee | $960.00 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Exelixis Inc. | $211,904 | 438 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $31,625 | 41 | $0 (2024) |
| TAIHO ONCOLOGY, INC. | $960.00 | 1 | $0 (2023) |
| Bayer HealthCare Pharmaceuticals Inc. | $188.59 | 2 | $0 (2022) |
| Astellas Pharma US Inc | $89.47 | 1 | $0 (2023) |
| Smith+Nephew, Inc. | $16.08 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $58,149 | 96 | Takeda Pharmaceuticals U.S.A., Inc. ($31,625) |
| 2023 | $35,459 | 90 | Exelixis Inc. ($34,393) |
| 2022 | $80,011 | 160 | Exelixis Inc. ($79,938) |
| 2021 | $71,165 | 138 | Exelixis Inc. ($71,049) |
All Payment Transactions
484 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Exelixis Inc. | CABOMETYX (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $1,650.00 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 12/11/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $81.09 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 11/25/2024 | Exelixis Inc. | CABOMETYX (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $1,650.00 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 11/21/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,100.00 | General |
| Category: ONCOLOGY | ||||||
| 11/21/2024 | Exelixis Inc. | CABOMETYX (Drug) | Travel and Lodging | In-kind items and services | $980.99 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 11/21/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Travel and Lodging | In-kind items and services | $478.66 | General |
| Category: ONCOLOGY | ||||||
| 11/19/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $117.20 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 11/15/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Food and Beverage | In-kind items and services | $118.53 | General |
| Category: ONCOLOGY | ||||||
| 11/08/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Travel and Lodging | In-kind items and services | $278.32 | General |
| Category: ONCOLOGY | ||||||
| 11/07/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Travel and Lodging | In-kind items and services | $142.32 | General |
| Category: ONCOLOGY | ||||||
| 10/24/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,100.00 | General |
| Category: ONCOLOGY | ||||||
| 10/22/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Travel and Lodging | In-kind items and services | $499.83 | General |
| Category: ONCOLOGY | ||||||
| 10/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Travel and Lodging | In-kind items and services | $522.30 | General |
| Category: ONCOLOGY | ||||||
| 10/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Travel and Lodging | In-kind items and services | $189.20 | General |
| Category: ONCOLOGY | ||||||
| 10/08/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Travel and Lodging | In-kind items and services | $149.10 | General |
| Category: ONCOLOGY | ||||||
| 10/08/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Food and Beverage | In-kind items and services | $110.39 | General |
| Category: ONCOLOGY | ||||||
| 10/08/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Food and Beverage | In-kind items and services | $96.33 | General |
| Category: ONCOLOGY | ||||||
| 10/01/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Travel and Lodging | In-kind items and services | $1,228.11 | General |
| Category: ONCOLOGY | ||||||
| 09/27/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $465.00 | General |
| Category: ONCOLOGY | ||||||
| 09/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,100.00 | General |
| Category: ONCOLOGY | ||||||
| 09/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Travel and Lodging | In-kind items and services | $674.32 | General |
| Category: ONCOLOGY | ||||||
| 09/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Travel and Lodging | In-kind items and services | $1,086.33 | General |
| Category: ONCOLOGY | ||||||
| 09/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Travel and Lodging | In-kind items and services | $121.10 | General |
| Category: ONCOLOGY | ||||||
| 09/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Food and Beverage | In-kind items and services | $103.29 | General |
| Category: ONCOLOGY | ||||||
| 09/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Travel and Lodging | In-kind items and services | $208.15 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 68 | 344 | $57,026 | $22,540 |
| 2022 | 2 | 93 | 332 | $44,788 | $20,986 |
| 2021 | 2 | 101 | 244 | $31,199 | $15,878 |
| 2020 | 2 | 49 | 130 | $16,790 | $6,496 |
Total Patients
311
Total Services
1,050
Medicare Billing
$65,900
Procedure Codes
7
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 68 | 344 | $57,026 | $22,540 | 39.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 70 | 296 | $41,440 | $19,645 | 47.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 23 | 36 | $3,348 | $1,341 | 40.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 64 | 181 | $25,340 | $12,847 | 50.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 37 | 63 | $5,859 | $3,032 | 51.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 32 | 100 | $14,000 | $5,542 | 39.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 17 | 30 | $2,790 | $953.47 | 34.2% |
About Abigail Graeber, CRNP
Abigail Graeber, CRNP is a Adult Health healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/19/2014. The National Provider Identifier (NPI) number assigned to this provider is 1316358807.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Abigail Graeber, CRNP has received a total of $244,783 in payments from pharmaceutical and medical device companies, with $58,149 received in 2024. These payments were reported across 484 transactions from 6 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($128,054).
As a Medicare-enrolled provider, Graeber has provided services to 311 Medicare beneficiaries, totaling 1,050 services with total Medicare billing of $65,900. Data is available for 4 years (2020–2023), covering 7 distinct procedure/service records.
Ad
Practice Information
- Specialty Adult Health
- Location Philadelphia, PA
- Active Since 05/19/2014
- Last Updated 01/22/2026
- Taxonomy Code 363LA2200X
- Entity Type Individual
- NPI Number 1316358807
Products in Payments
- CABOMETYX (Drug) $131,927
- Cabometyx (Drug) $79,978
- FRUZAQLA (Drug) $31,625
- LONSURF (Drug) $960.00
- Nubeqa (Drug) $115.40
- Vitrakvi (Drug) $73.19
- RENASYS GO v2 HOME (Device) $16.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Adult Health Doctors in Philadelphia
Beth Sandy, Crnp, CRNP
Adult Health — Payments: $708,588
Adult Health $708,588
Diane Newman, Crnp, CRNP
Adult Health — Payments: $293,796
Adult Health $293,796
Ms. Catherine Holdsworth, Crnp, CRNP
Adult Health — Payments: $64,391
Adult Health $64,391
Christine Chmielewski, Crnp, CRNP
Adult Health — Payments: $51,529
Adult Health $51,529
Mr. Kevin Carney, Crnp, CRNP
Adult Health — Payments: $44,425
Adult Health $44,425
Joyce Ross, Crnp, CRNP
Adult Health — Payments: $39,097
Adult Health $39,097